UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 2)*
DURA PHARMACEUTICALS INC
____________________________________________________
(Name of Issuer)
Common Stock
____________________________________________________
(Title of Class of Securities)
26632S109
____________________________________________________
(CUSIP NUMBER)
Check the following box if a fee is being paid with
this statement ( ). (A fee is not required only if
the filing person: (1) has a previous statement on
file reporting beneficial ownership of more than
five percent of the class of securities described in
Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five
percent or less of such class.) (See Rule 13d-7).
* The remainder of this cover page shall be filled
out for a reporting person's initial filing on this
form with respect to the subject class of securities,
and for any subsequent amendment containing
information which would alter the disclosures
provided in a prior cover page. The information
required in the remainder of this cover page shall
not be deemed to be "filed" for the purpose of
Section 18 of the Securities and Exchange Act of
1934 ("Act") or otherwise subject to the liabilities
of that section of the Act but shall be subject to
all other provisions of the Act (however, see the
Notes).
<PAGE> 2 of 7
CUSIP NO. 26632S109 13G
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE
PERSON
George D. Bjurman & Associates
IRS Identification No. 95-2654860
____________________________________________________
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A
GROUP
(a) ______
(b) ______
____________________________________________________
3. SEC USE ONLY
____________________________________________________
4. CITIZENSHIP OR PLACE OF ORGANIZATION
California
____________________________________________________
5. SOLE VOTING POWER
682,145
NUMBER OF SHARES 6. SHARED VOTING POWER
BENEFICIALLY -0-
OWNED BY EACH REPORTING 7. SOLE DISPOSITIVE
PERSON WITH POWER
682,145
8. SHARED DISPOSITIVE
POWER
-0-
____________________________________________________
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH
REPORTING PERSON
682,145
______________________________________________________________
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
EXCLUDES CERTAIN SHARES
N/A
______________________________________________________________
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN
ROW 9
4.89%
______________________________________________________________
12. TYPE OF REPORTING PERSON
IA
<PAGE> 3 of 7
CUSIP NO. 26632S109
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE
PERSON
George Andrew Bjurman*
###-##-####
____________________________________________________
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A
GROUP
(a) ______
(b) __X___
____________________________________________________
3. SEC USE ONLY
____________________________________________________
4. CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.A.
____________________________________________________
5. SOLE VOTING POWER
-0-
NUMBER OF SHARES 6. SHARED VOTING POWER
BENEFICIALLY 682,145*
OWNED BY EACH REPORTING 7. SOLE DISPOSITIVE
PERSON WITH POWER
-0-
8. SHARED DISPOSITIVE
POWER
682,145*
____________________________________________________
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH
REPORTING PERSON
682,145*
____________________________________________________
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
EXCLUDES CERTAIN SHARES
N/A
____________________________________________________
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN
ROW 9
4.89%
____________________________________________________
12. TYPE OF REPORTING PERSON
IN
*The filing of this statement shall not be deemed an
admission by George Andrew Bjurman that he
beneficially owns the securities attributed to George
D. Bjurman Associates for any purpose.
<PAGE> 4 of 7
CUSIP NO. 26632S109 13G
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE
PERSON
Owen Thomas Barry III*
###-##-####
____________________________________________________
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A
GROUP
(a) ______
(b) __X___
____________________________________________________
3. SEC USE ONLY
____________________________________________________
4. CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.A.
____________________________________________________
5. SOLE VOTING POWER
-0-
NUMBER OF SHARES 6. SHARED VOTING POWER
BENEFICIALLY 682,145*
OWNED BY EACH REPORTING 7. SOLE DISPOSITIVE
PERSON WITH POWER
-0-
8. SHARED DISPOSITIVE
POWER
682,145*
____________________________________________________
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH
682,145*
____________________________________________________
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
EXCLUDES CERTAIN SHARES
N/A
____________________________________________________
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN
ROW 9
4.89%
____________________________________________________
12. TYPE OF REPORTING PERSON
IN
* The filing of this statement shall not be
deemed an admission by Owen Thomas Barry III that
he beneficially owns the securities attributed to
George D. Bjurman Associates for any purpose.
<PAGE> 5 of 7
Item 1.
(a) Name of Issuer:
Dura Pharmaceuticals Inc
(b) Address of Issuer's Principal Executive
Offices:
5880 Pacific Center Blvd.
San Diego, CA 92121-4204
Item 2.
(a) Name of Persons Filing:
George D. Bjurman Associates
("GDBA"),George Andrew Bjurman*
and Owen Thomas Barry III*.
*These individuals may, as a result
of their ownership in and positions
with GDBA, be deemed to be indirect
beneficial owners of the equity
securities held by GDBA. The filing
of this statement shall not be deemed
an admission by George Andrew Bjurman
and Owen Thomas Barry that either
person beneficially owns the
securities attributed to GDBA for any
purpose, regardless of whether they
are acting in concert or acting severally.
(b) Address of Principal Business Office or,
if none, Residence:
The business address for GDBA
and Messrs. Bjurman and Barry is 10100
Santa Monica Boulevard, Suite 1200,
Los Angeles, CA 90067.
(c) Citizenship:
GDBA is a corporation organized
under the laws of California. Messrs.
Bjurman and Barry are United States
citizens.
(d) Title of Class of Securities:
Common Stock
(e) CUSIP Number:
26632S109
Item 3. If this statement is filed pursuant to Rule
13d-1(b), or 13d-2(b), check whether the person
filing is a:
GDBA is an Investment Adviser registered
under section 203 of the Investment
Advisers Act of 1940.
<PAGE> 6 of 7
Item 4. Ownership.
(a) Amount Beneficially Owned:
As of May 31, 1996, GDBA
beneficially owned 682,145 shares.
*Messrs. Bjurman and Barry III may,
as a result of their ownership in
and positions with GDBA, be deemed
to be indirect beneficial owners
of the equity securities held by GDBA.
(b) Percent of Class:
4.89%
(c) Number of shares as to which such person
has:
(i)sole power to vote or to
direct the vote:
-0-
(ii)shared power to vote or to
direct the vote:
682,145**
(iii)sole power to dispose
or to direct the disposition of:
-0-
(iv)shared power to dispose or
to direct the disposition of:
682,145**
**GDBA, as an investment adviser,
shares such powers only to the
extent that its clients may be able
to give instructions that would
supersede GDBA's otherwise full
discretionary authority over the
disposition or voting of the
securities in its portfolios.
Item 5. Ownership of Five Percent or Less of a Class.
Not Applicable
Item 6. Ownership of More than Five Percent on Behalf
of Another Person.
Not Applicable
Item 7. Identification and Classification of the
Subsidiary Which Acquired the Security Being
Reported on By the Parent Holding Company.
Not Applicable
Item 8. Identification and Classification of Members
of the Group.
Not Applicable
Item 9. Notice of Dissolution of Group.
Not Applicable
<PAGE> 7 of 7
Item 10. Certification and Signature.
By signing below I certify that, to the best
of my knowledge and belief, the securities
referred to above were acquired in the
ordinary course of business and were not
acquired for the purpose of and do not have
the effect of changing or influencing the
control of the issuer of such securities and
were not acquired in connection with or as a
participant in any transaction having such
purposes or effect.
SIGNATURE
After reasonable inquiry and to the best of
my knowledge and belief, I certify that the
information set forth in this statement is
true, complete and correct.
06/05/96
_____________
Date
/s/ George Andrew Bjurman
________________________
Signature
George Andrew Bjurman
CEO,GDBA
________________________
Name/Title
/s/ George Andrew Bjurman
_________________________
George Andrew Bjurman
/s/ Owen Thomas Barry III
_________________________
Owen Thomas Barry III
